Levotyroksinnatrium Accord (Levothyroxine Sodium)

Levothyroxine sodium is a pro‑hormone that is absorbed from the gastrointestinal tract and converted to the active hormone triiodothyronine (T3) in peripheral tissues. T3 binds to nuclear thyroid hormone receptors, influencing gene transcription that regulates basal metabolic rate, protein synthesis, and growth, thereby restoring normal metabolic function.

The appropriate dose of Levotyroksinnatrium Accord is determined individually by a prescriber based on the patient’s serum TSH and free T4 levels, age, weight, cardiac status, and other clinical factors. Patients should follow the dosing instructions provided by their healthcare professional and have regular laboratory monitoring.

Levothyroxine is classified as a pregnancy‑category drug where the benefits usually outweigh potential risks because untreated hypothyroidism can harm both mother and fetus. Pregnant or breastfeeding patients should discuss dose adjustments with their physician, as thyroid hormone requirements often increase during these periods.

To order Levotyroksinnatrium Accord, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Levotyroksinnatrium Accord provides levothyroxine sodium, the standard of care for thyroid hormone replacement. Compared with liothyronine (T3) preparations, levothyroxine offers a longer half‑life and more stable serum levels, allowing once‑daily dosing. It is generally preferred for most patients, while combination therapy may be considered in select cases.

Levotyroksinnatrium Accord should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments.

Levotyroksinnatrium Accord is taken orally, usually on an empty stomach 30‑60 minutes before breakfast with a full glass of water. Swallow the tablet whole; do not crush or chew it. Consistent timing each day helps maintain stable hormone levels.

Serious risks include cardiac arrhythmias, angina, or myocardial infarction in patients with underlying heart disease, as well as severe allergic reactions such as rash, swelling, or anaphylaxis. Over‑replacement can lead to symptoms of hyperthyroidism, including bone loss and muscle weakness. Prompt medical attention is required if these occur.

Levotyroksinnatrium Accord should be avoided in patients with known hypersensitivity to levothyroxine or any of the tablet excipients. Caution is advised for individuals with untreated adrenal insufficiency, acute myocardial infarction, or uncorrected thyrotoxicosis, as hormone replacement may exacerbate these conditions.